Long-term prognosis of unrecognized myocardial infarction in women and men from the general population: the Rotterdam Study - Top-Institutions - MDSpire

Long-term prognosis of unrecognized myocardial infarction in women and men from the general population: the Rotterdam Study

  • By

  • Julie A E van Oortmerssen

  • Luoshiyuan Zuo

  • Martijn J Tilly

  • Bryn Hummel

  • M Kamran Ikram

  • Eric Boersma

  • Jeanine E Roeters van Lennep

  • Maryam Kavousi

  • October 27, 2025

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Cardiovascular Epidemiology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Epidemiology

  • #3

    Harvard Medical School / Brigham and Women’s Hospital
    Harvard Medical School / Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Cardiovascular Research

  • #4

    University of Rotterdam / Erasmus MC
    University of Rotterdam / Erasmus MC

    Rotterdam, South Holland

    Key Differentiators

    • Cardiology
    • Epidemiology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Cardiovascular Imaging

Original Source(s)

Long-term prognosis of unrecognized myocardial infarction in women and men from the general population: the Rotterdam Study

  • by Julie A E van Oortmerssen, Luoshiyuan Zuo, Martijn J Tilly, Bryn Hummel, M Kamran Ikram, Eric Boersma, Jeanine E Roeters van Lennep, Maryam Kavousi

  • October 27, 2025

Related Content

Heterogeneous benefit of early sacubitril/valsartan initiation after PCI in elderly patients with left ventricular dysfunction: myocardial recovery and mid-term cardiovascular outcomes

Safety and efficacy of sacubitril/valsartan vs. benazepril administered as initial treatment for STEMI patients with mid-range ejection fraction: a propensity score matching analysis

Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors